#ESHREjc report: is OTO-IVM the future fertility preservation alternative for urgent cancer patients?

Documenti analoghi

• #ESHREjc live edition report: ‘the forgotten Y’—advanced paternal age from a global health perspective
  di: Massarotti, C, et al.
  Pubblicazione: (2021)
• #ESHREjc report: trick or treatment—evidence based use of add-ons in ART and patient perspectives
  di: Liperis, G, et al.
  Pubblicazione: (2021)
• OTO-IVM is a method of fertility preservation for patients with ovarian tumors
  di: O. E. Lavrinovich, et al.
  Pubblicazione: (2024-09-01)
• #ESHREjc report: ovarian stimulation practice after the OPTIMIST trial and evidence-based medicine
  di: Makieva, S, et al.
  Pubblicazione: (2021)
• Mind the gap: deciphering the role of anti-Müllerian hormone in follicular development-from animal studies toward clinical application
  di: Fraire-Zamora, JJ, et al.
  Pubblicazione: (2023)